Pembrolizumab with or Without Lenvatinib as First-line Therapy for Patients with Advanced Urothelial Carcinoma (LEAP-011): A Phase 3, Randomized, Double-Blind Trial

Autor: Matsubara, Nobuaki, de Wit, Ronald, Balar, Arjun Vasant, Siefker-Radtke, Arlene O., Zolnierek, Jakub, Csoszi, Tibor, Shin, Sang Joon, Park, Se Hoon, Atduev, Vagif, Gumus, Mahmut, Su, Yu-Li, Karaca, Saziye Burcak, Cutuli, Hernán Javier, Sendur, Mehmet A.N., Shen, Liji, O'Hara, Karen, Okpara, Chinyere E., Franco, Sonia, Moreno, Blanca Homet, Grivas, Petros, Loriot, Yohann
Zdroj: In European Urology March 2024 85(3):229-238
Databáze: ScienceDirect
Externí odkaz: